|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| The contraceptive use of Depo-Provera in U.S. adolescents. |
| JOURNAL OF ADOLESCENT HEALTH. 1995 May;16(5):347-9. |
| Although Depo-Provera has the potential to reduce the unintended pregnancy rate among US adolescents, its |
| acceptability and safety as a contraceptive method for young women remain undetermined. To address this research |
| gap, in 1992--prior to the US Food and Drug Administration's approval of depot medroxyprogesterone acetate for |
| contraceptive purposes--questionnaires were mailed to physician members of the Society of Adolescent Medicine |
| and the North American Society of Pediatric and Adolescent Gynecology regarding their experiences. Responses |
| were received from 616 (60%) physicians. 87% had prescribed contraceptives to adolescents and 218 (41%) had |
| prescribed Depo-Provera, for an average of eight years. Obstetrician respondents were significantly more likely than |
| pediatricians to have prescribed this method. Adolescent Depo-Provera patients fell into three major groups: |
| mentally retarded adolescents, 43%; those with medical conditions that precluded estrogen use, 24%; and other |
| (e.g., teen mothers, those with a history of poor compliance with other methods). 27% of physicians acknowledged |
| providing Depo-Provera to minors without parental consent and 75% had no written protocol for Depo-Provera use. |
| 85% of adolescent Depo-Provera users continued the method for at least nine months; 40% continued beyond 21 |
| months. Menstrual irregularity and loss to follow-up were the main reasons for discontinuation. (PubHealth.info |
| Document ID: CONT2T 2505-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "The contraceptive use of Depo-Provera in U.S. |
| adolescents.", is(are) Koenigs LM; Miller NH. The source of this article is "JOURNAL OF ADOLESCENT HEALTH. |
| 1995 May;16(5):347-9.". This article was published in 1995 in English language(s). (PubHealth.info® Document ID: |
| CONT2T 2505-06. All rights reserved with PubHealth.info) PIN: 7505 |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |